Showing results (11-20 of 170) with videos related to

Sort By:
Pageof 17
Expert Opinion on Investigational Drugs|October 10, 2007
The therapeutic role of targeting protein kinase C in solid and hematologic malignanciesKlaus Podar, Marc S Raab, Dharminder Chauhan, et al.
Leukemia|May 20, 2020
Proteomic analysis identifies mechanism(s) of overcoming bortezomib resistance via targeting ubiquitin receptor Rpn13Ting Du, Yan Song, Arghya Ray, et al.
Leukemia Research|January 17, 2002
Growth inhibition and apoptosis of myeloma cells by the CDK inhibitor flavopiridolIgor Semenov, Canan Akyuz, Vera Roginskaya, et al.
Molecular Cancer Therapeutics|April 14, 2005
Proteasome inhibitor therapy in multiple myelomaDharminder Chauhan, Teru Hideshima, Constantine Mitsiades, et al.
Oncogene|February 7, 2020
Preclinical validation of Alpha-Enolase (ENO1) as a novel immunometabolic target in multiple myelomaArghya Ray, Yan Song, Ting Du, et al.
Analytical Chemistry|March 12, 2014
A nano ultra-performance liquid chromatography-high resolution mass spectrometry approach for global metabolomic profiling and case study on drug-resistant multiple myelomaDrew R Jones, Zhiping Wu, Dharminder Chauhan, et al.
Oncogene|December 4, 2003
Biologic sequelae of c-Jun NH(2)-terminal kinase (JNK) activation in multiple myeloma cell linesTeru Hideshima, Toshiaki Hayashi, Dharminder Chauhan, et al.
Best Practice & Research. Clinical Haematology|December 12, 2007
The malignant clone and the bone-marrow environmentKlaus Podar, Paul G Richardson, Teru Hideshima, et al.
Leukemia|August 30, 2019
Targeting tryptophan catabolic kynurenine pathway enhances antitumor immunity and cytotoxicity in multiple myelomaArghya Ray, Yan Song, Ting Du, et al.
Hematology/Oncology Clinics of North America|September 13, 2014
Novel targeted agents in the treatment of multiple myelomaCindy Varga, Jacob Laubach, Teru Hideshima, et al.
Pageof 17